These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23589551)

  • 1. Genomic medicine frontier in human solid tumors: prospects and challenges.
    Dienstmann R; Rodon J; Barretina J; Tabernero J
    J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-driven patient selection for early clinical trials.
    Dienstmann R; Rodon J; Tabernero J
    Curr Opin Oncol; 2013 May; 25(3):305-12. PubMed ID: 23493192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment.
    Buettner R; Wolf J; Thomas RK
    J Clin Oncol; 2013 May; 31(15):1858-65. PubMed ID: 23589544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
    Arnedos M; Vielh P; Soria JC; Andre F
    J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
    Cloonan N; Waddell N; Grimmond SM
    IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing genomic medicine in pathology.
    Williams ES; Hegde M
    Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future of clinical genomics in pediatric oncology.
    Janeway KA; Place AE; Kieran MW; Harris MH
    J Clin Oncol; 2013 May; 31(15):1893-903. PubMed ID: 23589558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision oncology: an overview.
    Garraway LA; Verweij J; Ballman KV
    J Clin Oncol; 2013 May; 31(15):1803-5. PubMed ID: 23589545
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing transformative clinical trials in the cancer genome era.
    Sleijfer S; Bogaerts J; Siu LL
    J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics and epigenomics: new promises of personalized medicine for cancer patients.
    Schweiger MR; Barmeyer C; Timmermann B
    Brief Funct Genomics; 2013 Sep; 12(5):411-21. PubMed ID: 23814132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer genomics: technology, discovery, and translation.
    Tran B; Dancey JE; Kamel-Reid S; McPherson JD; Bedard PL; Brown AM; Zhang T; Shaw P; Onetto N; Stein L; Hudson TJ; Neel BG; Siu LL
    J Clin Oncol; 2012 Feb; 30(6):647-60. PubMed ID: 22271477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.